Glial cell line-derived neurotrophic factor gene delivery via a polyethylene imine grafted chitosan carrier

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3163-3174

  Peng, Yu Shiang ^a   Lai, Po Liang ^b   Peng, Sydney ^a   Wu, His Chin ^c   Yu, Siang ^a   Tseng, Tsan Yun ^d   Wang, Li Fang ^e   Chu, I Ming ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c TATUNG UNIVERSITY   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chitosan; Gene transfection; Glial cell; Parkinson's disease; Polyethylene imine

Indexed keywords

CHITOSAN; COPOLYMER; ETHYLENE GLYCOL DERIVATIVE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MACROGOL; PLASMID DNA; POLY(ETHYLENE GLYCOL)DIGLYCIDYL ETHER; POLYETHYLENEIMINE; UNCLASSIFIED DRUG; CHITOSAN-GRAFT-POLYETHYLENIMINE; DNA; DRUG CARRIER; NANOPARTICLE;

ARTICLE; BLOOD BRAIN BARRIER; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DEACETYLATION; DRUG SOLUBILITY; ENDOSOME; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NEUROPROTECTION; PARKINSON DISEASE; PARTICLE SIZE; PLASMID; POLYMERIZATION; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; PROCEDURES; SOLUBILITY; TOXICITY;

CELL LINE; CELL SURVIVAL; CHITOSAN; DNA; DRUG CARRIERS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NANOPARTICLES; POLYETHYLENEIMINE; SOLUBILITY; TRANSFECTION;

EID: 84903625404     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S60465     Document Type: Article

References (39)

1. Hu FQ, Chen WW, Zhao MD, Yuan H, Du YZ. Effective antitumor gene therapy delivered by polyethylenimine-conjugated stearic acid-g-chitosan oligosaccharide micelles. Gene Ther. 2013;20(6): 597-606.
2. Huh MS, Lee SY, Park S, et al. Tumor-homing glycol chitosan/ polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J Control Release. 2010;144(2):134-143.
3. Oliveira H, Pires LR, Fernandez R, Martins MC, Simões S, Pêgo AP. Chitosan-based gene delivery vectors targeted to the peripheral nervous system. J Biomed Mater Res A. 2010;95(3):801-810.
4. Muramatsu S. Gene therapy for Parkinson disease. Nihon Rinsho. 2010;68 Suppl 8:646-649. Japanese.
5. Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 2006;58(4):467-486.
6. Wu TL, Ertl HC. Immune barriers to successful gene therapy. Trends Mol Med. 2009;15(1):32-39.
7. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999;286(5448):2244-2245.
8. Kato T, Iwamoto K, Ando H, et al. Synthetic cationic amphiphile for liposome-mediated DNA transfection with less cytotoxicity. Biol Pharm Bull. 1996;19(6):860-863.
9. Anderson WF. Human gene therapy. Nature. 1998;392(6679 Suppl): 25-30.
10. Köping-Höggård M, Tubulekas I, Guan H, et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 2001;8(14):1108-1121.
11. Jiang HL, Kim YK, Arote R, et al. Chitosan-graft-polyethylenimine as a gene carrier. J Control Release. 2007;117(2):273-280.
12. Toh EK, Chen HY, Lo YL, Huang SJ, Wang LF. Succinated chitosan as a gene carrier for improved chitosan solubility and gene transfection. Nanomedicine. 2011;7(2):174-183.
13. Kadiyala I, Loo Y, Roy K, Rice J, Leong KW. Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes. Eur J Pharm Sci. 2010;39(1-3): 103-109.
14. Dai H, Jiang X, Tan GC, et al. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine. 2006;1(4):507-522.
15. Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine. 2006;1(2):117-128.
16. Lo YL, Sung KH, Chiu CC, Wang LF. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery. Mol Pharm. 2013;10(2):664-676.
17. Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med. 2005;7(8):992-1009.
18. Zhang L, Chen Z, Li Y. Dual-degradable disulfide-containing PEI- Pluronic/DNA polyplexes: transfection efficiency and balancing protection and DNA release. Int J Nanomedicine. 2013;8:3689-3701.
19. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995;92(16):7297-7301.
20. Shi S, Guo Q, Kan B, et al. A novel poly(epsilon-caprolactone)-pluronicpoly(epsilon-caprolactone) grafted polyethyleneimine(PCFC-g-PEI), Part 1, synthesis, cytotoxicity, and in vitro transfection study. BMC Biotechnol. 2009;9:65-76.
21. Fernandes JC, Qiu X, Winnik FM, et al. Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro. Int J Nanomedicine. 2013;8: 4091-4102.
22. Shastry BS. Parkinson disease: etiology, pathogenesis and future of gene therapy. Neurosci Res. 2001;41(1):5-12.
23. Sajadi A, Bensadoun JC, Schneider BL, Lo Bianco C, Aebischer P. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiol Dis. 2006;22(1):119-129.
24. Kells AP, Eberling J, Su X, et al. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2- GDNF. J Neurosci. 2010;30(28):9567-9577.
25. Bolliet C, Bohn MC, Spector M. Non-viral delivery of the gene for glial cell line-derived neurotrophic factor to mesenchymal stem cells in vitro via a collagen scaffold. Tissue Eng Part C Methods. 2008;14(3): 207-219.
26. Li ZT, Guo J, Zhang JS, et al. Chitosan-graft-polyethylenimine with improved properties as a potential gene vector. Carbohyd Polym. 2010;80(1):254-259.
27. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliver Rev. 2001;53(3): 341-358.
28. Kubota N, Tatsumoto N, Sano T, Toya K. A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohydr Res. 2000;324(4):268-274.
29. Mao S, Shuai X, Unger F, Simon M, Bi D, Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm. 2004;281(1-2):45-54.
30. Lou YL, Peng YS, Chen BH, Wang LF, Leong KW. Poly(ethylene imine)-g-chitosan using EX-810 as a spacer for nonviral gene delivery vectors. J Biomed Mater Res A. 2009;88(4):1058-1068.
31. Malhotra M, Tomaro-Duchesneau C, Prakash S. Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials. 2013;34(4): 1270-1280.
32. Intra J, Salem AK. Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo. J Control Release. 2008;130(2):129-138.
33. Huang SJ, Wang TP, Lue SI, Wang LF. Pentablock copolymers of pluronic F127 and modified poly(2-dimethyl amino)ethyl methacrylate for internalization mechanism and gene transfection studies. Int J Nanomedicine. 2013;8:2011-2027.
34. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 2004;57(1):1-8.
35. Khan M, Ang CY, Wiradharma N, et al. Diaminododecane-based cationic bolaamphiphile as a non-viral gene delivery carrier. Biomaterials. 2012;33(18):4673-4680.
36. Liu YM, Reineke TM. Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. J Am Chem Soc. 2005;127(9):3004-3015.
37. Wu HC, Wang TW, Bohn MC, Lin FH, Spector M. Novel magnetic hydroxyapatite nanoparticles as non-viral vectors for the glial cell line-derived neurotrophic factor gene. Adv Funct Mater. 2010;20(1): 67-77.
38. Petersen H, Fechner PM, Martin AL, et al. Polyethylenimine-graft- poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem. 2002;13(4):845-854.
39. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res. 1999;16(8):1273-1279.